Merck & Co., Inc. EVAX Holdings History

Number of Shares
1.21 Mil
Current Holdings Value*
$2.25 Mil
% of Portfolio
1.37%
Total Estimate Gain
$-879,518.64
% of Total Estimate Gain
-21.40%

Merck & Co., Inc.'s Evaxion AS Holding Summary

As of 2025-03-31, Merck & Co., Inc. held 1.21 Mil shares of Evaxion AS(EVAX), totaling $2.25 Mil. This investment constitutes 1.37% of their stock portfolio, and Merck & Co., Inc. now holds 19.21% of the outstanding Evaxion AS(EVAX) stock.

The initial trade took place in 2024Q4. And since then Merck & Co., Inc. has made 1 purchases of EVAX, at an average price of $3.38, for a total of 1.21 Mil shares. Based on historical transaction data and EVAX's current price of $2.66, Merck & Co., Inc.'s estimated gain on his EVAX holdings is $-879,518.64, reflecting a -21.40% gain to date.

Merck & Co., Inc. EVAX ($2.66) Holding Chart

Merck & Co., Inc. EVAX ($2.66) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1